Related Experiment Video
Updated: May 29, 2026

06:39
Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
Acremonium keratomycosis in a cat
Daniel R Binder1, Jesse E Sugrue, Ian P Herring
1Department of Small Animal Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg, VA 24061-0442, USA.
Veterinary Ophthalmology
|September 20, 2011
Summary
A cat with a fungal eye infection, Acremonium keratitis, showed improvement with topical voriconazole after initial miconazole treatment failed. This case highlights effective treatment for fungal keratitis in cats.
Area of Science:
- Veterinary Ophthalmology
- Mycology
- Infectious Diseases
Background:
- Fungal keratitis is a challenging ocular disease in cats, often requiring prompt diagnosis and targeted therapy.
- Superficial corneal ulceration can progress to severe stromal loss if left untreated, leading to potential vision impairment.
Observation:
- A 14-year-old cat presented with progressive superficial corneal ulceration, mucoid discharge, and blepharospasm.
- Ocular examination revealed ulcerative keratitis with stromal loss, chemosis, corneal edema, miosis, aqueous flare, and hyphema.
- Corneal cytology identified branching, septate fungal hyphae, and fungal culture confirmed Acremonium species.
Findings:
- Initial treatment with topical 1% miconazole led to clinical deterioration.
- Switching to topical 1% voriconazole solution successfully resolved the Acremonium fungal keratitis.
- PCR testing of cytology samples was negative for fungal elements despite positive culture and cytology findings.
Implications:
- Topical voriconazole demonstrates clinical efficacy in treating feline fungal keratitis caused by Acremonium.
- Discrepancies between in vitro antifungal susceptibility and clinical outcomes warrant further investigation.
- This case underscores the importance of considering fungal etiologies in refractory ulcerative keratitis and adapting treatment based on clinical response.
